Study Group: HIV Specialists (EU)(?)

The HLAB5701 test  is inexpensive and uncomplicated to perform  It reduces risk of the hypersenitivity reaction.  Two recent studies have raised  concerns about abacavir. -ACTG 5202 study has indicated that in persons with high viral loads epzicom (the main brand of abacavir)...

Impressive 7 day antiviral effects Potential for QD naive and BD experienced approaches Potential for coformulations Revised formulation moving into next phase of testing No critical safety issues in volunteers or patients Metabolit may be anti-gout agent

HIV therapy must be the strongest and the most safe therapy ; NNRTI are the key drugs for this kind of therapy. When you,doctor,begin a  naive HIV therapy, you must think that your patient should be treated for a very long time , maybe for a whole life period ; it'simportant...

Atripla is a fixed combination in a single pill of three excellent antiretroviral drugs with very good pharmacokinetics profile and fairly good tolerability. It will have a considerable impact on compliance as it can be taken once daily. If compliance will be as good as predictable, the chances that...

While ideally Maraviroc would now be approved the requests from the FDA do not require new clinical trials. The main issues relate to the failings of other drugs in this class Aplaviroc (Ono/GSK) discontinued for hepatotoxicity and questions over malignancies with Vicriviroc (Schering-Plough). Data...